Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor We apologize to the editors and readers of JAMA Psychiatry for our failure to fully disclose our financial interests in an article1 that reported a diagnostic tool, the Computerized Adaptive Test for Depression (CAT-DI). Following acceptance of the paper, we disclosed that “The CAT-DI will ultimately be made available for routine administration, and its development as a commercial product is under consideration.” The company that owns the rights to CAT-DI and several related tests is Psychiatric Assessments, Inc (PAI), which uses the trade name of Adaptive Testing Technologies (ATT) on a website describing these tests.
Gibbons RD, Weiss DJ, Pilkonis PA, Frank E, Kupfer DJ. Failure to Report Financial Disclosure Information. JAMA Psychiatry. 2014;71(1):95. doi:10.1001/jamapsychiatry.2013.3888